Weight Reduction Medications
Some weight loss medications for treating obesity are covered under the New Mexico Medicaid Fee-for-Service program with prior authorization.
| Covered, Prior Authorization Required | Not Covered by New Mexico Medicaid |
|---|---|
| Didres (benzphetamine) | Imcivree (setmelanotide) |
| Fastin (phentermine HCL) | Saxenda (liraglutide) |
| Meridia (sibutramine HCL M-hydrate) | Wegovy (semaglutide) |
| Sanorex (mazindol) | Zepbound (tirzepatide) |
| Tenuate (phendimetrazine) | |
| Xenical (orlistat) |
Prior Authorization Criteria
- BMI >40 or BMI > 35 with additional risk factors (hypertension, diabetes, dyslipidemia), and
- A six-month trial of caloric restriction and exercise is recommended (not required).
Prior Authorization Process
- Providers: to obtain prior authorization, when necessary, fax MAD Form 635 to Medical Assistance division at 505-827-3185. Authorization is for an initial three-month period. Authorization for Meridia and Xenical is continued for a period of one year with significant weight loss (at least 3% body weight loss) and improvement of co-morbid conditions. Prior approval expires after a three-month period for all drugs indicated for short-term weight loss.
The New Mexico Medicaid program is approved to cover certain medications that are not typically covered by Medicare (see NMAC 8.324.4.12.A).
For more information contact: MADInfo.HCA@hca.nm.us